Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/24/18 → 10/23/20 |
Funding
- Syntimmune Incorporated: $161,700.00
Ancillary Study to Syntimmune, Inc. clinical trial "A Phase 1b, Multicenter, open-label, safety, tolerability, and activity study of SYNT001 in subjects with chronic pemphigus (Vulgaris or Foliaceus)"
- Sinha, Animesh (PI)
- Seiffert, Kristina (CoI)
Project: Research